- Home
- BOLT vs DRIO Comparison
BOLT vs DRIO Comparison
Compare BOLT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- DRIO
- Stock Information
- Founded
- BOLT 2015
- DRIO 2011
- Country
- BOLT United States
- DRIO United States
- Employees
- BOLT N/A
- DRIO N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- BOLT Health Care
- DRIO Health Care
- Exchange
- BOLT Nasdaq
- DRIO Nasdaq
- Market Cap
- BOLT 25.3M
- DRIO 25.1M
- IPO Year
- BOLT 2021
- DRIO N/A
- Fundamental
- Price
- BOLT $0.52
- DRIO $0.69
- Analyst Decision
- BOLT Hold
- DRIO Strong Buy
- Analyst Count
- BOLT 5
- DRIO 1
- Target Price
- BOLT $1.25
- DRIO $4.00
- AVG Volume (30 Days)
- BOLT 168.8K
- DRIO 121.6K
- Earning Date
- BOLT 11-12-2024
- DRIO 11-07-2024
- Dividend Yield
- BOLT N/A
- DRIO N/A
- EPS Growth
- BOLT N/A
- DRIO N/A
- EPS
- BOLT N/A
- DRIO N/A
- Revenue
- BOLT $9,779,000.00
- DRIO $23,052,000.00
- Revenue This Year
- BOLT $9.87
- DRIO $34.58
- Revenue Next Year
- BOLT N/A
- DRIO $36.01
- P/E Ratio
- BOLT N/A
- DRIO N/A
- Revenue Growth
- BOLT 35.86
- DRIO N/A
- 52 Week Low
- BOLT $0.50
- DRIO $0.65
- 52 Week High
- BOLT $1.56
- DRIO $2.60
- Technical
- Relative Strength Index (RSI)
- BOLT 38.20
- DRIO 42.80
- Support Level
- BOLT $0.50
- DRIO $0.70
- Resistance Level
- BOLT $0.59
- DRIO $0.80
- Average True Range (ATR)
- BOLT 0.03
- DRIO 0.05
- MACD
- BOLT -0.00
- DRIO 0.00
- Stochastic Oscillator
- BOLT 24.49
- DRIO 32.96
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.